Configuration Validated/Non Validated
Blueberry Therapeutics sign up to ComplianceControl Centre
Blueberry Therapeutics, a modern drug discovery and development company based at Alderley Park, Cheshire have signed up to ComplianceControl Centre (CCC). Blueberry Therapeutics have extensive knowledge and experience in developing drugs from the concept stage, through regulatory approval, clinical proof of concept and beyond.
Blueberry Therapeutics’ ultimate objective is to create novel, safer and effective medicines to treat diseases in both humans and animals. Blueberry Therapeutics focuses on the research and clinical development of treatments for inflammatory and infectious diseases such as inflammatory bowel disease, atopic dermatitis, acne, fungal diseases and anti-microbial resistance (AMR). Using its patented, safe, nanoparticle drug delivery platform, Blueberry is developing novel peptide medicines that directly target mechanisms of bacterial resistance. By doing this Blueberry can restore sensitivity of bacteria to standard antibiotics.
ComplianceControl Centre has recently launched version 3.5 of its electronic Document and Quality Management System, that will be used to cover all aspects of Blueberry Therapeutics’ Quality and Compliance Management system, including ISO 13485. The system will manage documentation, equipment, training records, audits, and corrective actions and preventative actions, to ensure proactive compliance management and will be particularly useful providing visibility of compliance across all the Blueberry Therapeutics offices and laboratories.
Dr Mike Davies, Blueberry’s Co-Founder and Chief Medical Officer, explained: “As we are now moving into the clinical phase of our business plan we needed to ensure that all our processes and data handling are compliant with current European and USA regulations. This is particularly important for our clinical trials programmes.
Blueberry is a small, agile company working across several locations and we wanted a simple, cost effective, and validated solution for a price that we could afford. The CCC “out of the box” solution allowed us to move quickly to a working system and we are very pleased with the service and support we have received from the company to date”.
Sean Forrest, Operations Manager of Compliance Control Ltd. stated: “We are pleased with the latest release of our software, which has been developed with help from the Technology Strategy Board Grant awarded in 2012 and funding from the Northwest Biomedical Fund. The new Software as a Service release really does mean that SME’s, like Blueberry Therapeutics, can now have access to Quality and Compliance software traditionally only available to larger organisations at an affordable price applicable to many small start-up and growing companies”.
Forrest continued: “Blueberry Therapeutics wanted a system that could be available and validated immediately, so that they could spend time using the system, not designing, customising and validating it. ComplianceControl Centre is an ‘Off the Shelf’ (GAMP®5 Category 3) product, which means that the system can be operational and fully validated within five days.”
ComplianceControl Centre, is a Software as a Service (SaaS) Electronic Quality and Document Management Software System that provides real-time visibility of the complete Quality, Compliance and Validation status of an organization.
Compliance Control Ltd. provide Compliance, Validation and Quality Consultancy Services and Products to the life science and pharmaceutical global markets. Services include Compliance and Validation planning and strategy, Documentation and Testing, along with a series of Auditing services and Computer System Validation Training courses.
For more information, please visit: www.compliance-control.com
Compliance Control Ltd.
Cheshire CW8 4DU
Contact person: Sean Forrest
+44 (0) 1606 871113
Blueberry Therapeutics Ltd.
Blueberry Therapeutics is a modern drug discovery and development company with a unique nanopolymer drug delivery technology. This opens up huge opportunity to rapidly develop new medicines, and help us find ways to treat infection and inflammation.
For more information, please visit: http://www.blueberrytherapeutics.com/
Blueberry Therapeutics Ltd.
The BioHub at Alderley Park
t: +44 (0) 1625 238776
<< News Index